Is Abivax SA Sponsored ADR (ABVX) Outperforming Other Medical Stocks This Year?Zacks Investment Research • 09/13/24
Wall Street Analysts Believe Abivax SA Sponsored ADR (ABVX) Could Rally 193.62%: Here's is How to TradeZacks Investment Research • 09/12/24
Abivax releases the results of its May 30, 2024 Ordinary and Extraordinary General MeetingGlobeNewsWire • 06/04/24
Abivax Announces Presentation of Four Abstracts for Obefazimod in Ulcerative Colitis and Sponsorship of Scientific Symposium at The 19th Congress of European Crohn's and Colitis Organization (ECCO)Accesswire • 02/13/24
Abivax Announces Closing of its Initial Public Offering on the Nasdaq Global MarketAccesswire • 10/24/23
U.S. IPO Weekly Recap: Big Launches And New Filings Keep The IPO Market MovingSeeking Alpha • 10/21/23
Abivax Announces the Pricing of its Initial Public Offering on the Nasdaq Global MarketAccesswire • 10/20/23
Abivax Announces Temporary Trading Halt of its Ordinary Shares on Euronext ParisAccesswire • 10/20/23
Abivax Announces the Filing of an Amended Registration Statement, Including an Estimated Initial Public Offering Price RangeAccesswire • 10/18/23
Abivax Announces the Start of the Roadshow for its Proposed Global Offering and Proposed Nasdaq ListingAccesswire • 10/16/23